The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro

The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro

Retinoid therapy is used for chemo-prevention in immuno-suppressed patients at high risk of developing skin cancer. The retinoid signalling molecule, tripartite motif protein 16 (TRIM16), is a regulator of keratinocyte differentiation and a tumour suppressor in retinoid-sensitive neuroblastoma. We s...

Full description

Bibliographic Details
Main Authors: Cheung, Belamy B, Koach, Jessica, Tan, Owen, Kim, Patrick, Bell, Jessica L, D'andreti, Carla, Sutton, Selina, Malyukova, Alena, Sekyere, Eric, Norris, Murray, Haber, Michelle, Kavallaris, Maria, Cunningham, Anne M, Proby, Charlotte, Leigh, Irene, Wilmott, James S, Cooper, Caroline L, Halliday, Gary M, Scolyer, Richard A, Marshall, Glenn M
Format: Online
Language:English
Published: John Wiley & Sons, Ltd. 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504077/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504077/

Similar Items